SlideShare a Scribd company logo
1 of 35
Pharmaceutical
Incompatibilities
Ubaid Ullah Anwer
Pharmaceutical Incompatibilities
• A problem arises during the pharmaceutical compounding of two or more
substances because of their therapeutic, physical or chemical properties the
substances are said to be incompatible
• Incompatibility is the result of mixing two or more antagonistic substances and is
detected by changes in physical and chemical or therapeutic qualities
• It may affect the safety efficacy and appearance of a medicine
• A prescription is considered to possess an incompatibility when the combination
of its ingredients adversely effects the appearance, elegance, safety or
therapeutic efficacy
Classification
• In general we can say there are two types of incompatibilities;
• Minor incompatibilities (which do not harm or which can be easily avoided)
• Major incompatibilities (which should not be dispensed)
• Incompatibilities can be classified into three classes;
• Physical incompatibilities
• Chemical incompatibilities
• Therapeutic incompatibilities
Therapeutic Incompatibilities
• Undesirable pharmacological interactions between two or more ingredients that
leads to
• Potentiation of each other’s therapeutic effect
• Destruction of effectiveness of any ingredient
• Occurrence of toxic manifestations within the patient
• Therapeutic incompatibility arises when a drug error, dosage error or a dosage
form error is made either by the physician in prescribing or by pharmacist in
counselling, prescription handling or compounding.
Therapeutic Incompatibilities: Drug Error
• Drug error can be made either by the physician or by the pharmacist. It can
be due to;
• Writing or speaking error by the physician in the verbal or non-verbal
prescription
• Reading or hearing error by the pharmacist in prescription handling
• Example:
• Such problems tends to arise with, incorrect drug due to trademark or
nomenclature error.
• Alphaden – Mineral supplement
• Alphalin – Vitamin A product
• Alphyllin – A diuretic
Therapeutic Incompatibilities:
Contraindicated Drugs
• Pharmacist should take history before dispensing the drug to the patient. So that;
• He must be aware of any sort of drug interaction
• He avoid dispensing a drug which undergo renal clearance, to a patient with
renal insufficiency
• He avoid dispensing a drug which mainly undergo hepatic metabolism, to a
patient with liver dysfunctioning
• He avoid dispensing morphine to an asthmatic patient
• He avoid dispensing vasoconstrictor to a hypersensitive patient
Therapeutic Incompatibilities: Dosage Form
Error
• These are the errors which occurs due to
• If the physician has asked to compound topical product and pharmacist
compounded an oral product
• If topical products is swallowed by the patient
• If skin dosages are instilled into eyes, nose or ears
• If auxiliary label is not mentioned on the final compounded product
Therapeutic Incompatibilities: Dosage Error
• If there is an error in dosage requirement, i.e. how to take? When to take? How
much to take? How long to take?
• Over dosage; Excessive single dosage because of decimal errors. It occurs if the
doctor wrote it wrong or pharmacist read it in a wrong way.
• Excessive daily dose; suppose doctor has to write ‘after every 4 hours’ but
mistakenly he wrote ‘after every 1 hour’ then by this error the patient will receive
over dosage of the medicament.
• Addictive or synergistic combination; Two drugs may have such relation that
when they are administered together, leads to more intense effect.
• Example: Morphine with Barbiturates produce intense CNS depressant action.
Therapeutic Incompatibilities: Dosage Error
• Antagonistic combination; Two drugs may have such relation leads to under
dosage to the patients.
• Example: The reduction of the anticoagulant effect of warfarin when an agent
that accelerates its hepatic metabolism, such as phenobarbital.
• In case of emulsion or suspension if patient forget to shaken the preparation
before usage, leads to unequal dosage to user.
Physical Incompatibilities
• Physical incompatibilities are those incompatibilities in which the physical
properties of ingredients produce a mixture unacceptable in appearance or
results in inaccuracy of dosage.
• Physical incompatibilities can arise due to following reasons
• Insolubility
• Liquefaction
• Immiscibility
Physical Incompatibilities: Insolubility
• In complete solution
• Addition of wrong solvents e.g. gum-alcohol, silicon-water
• Amount of solvent is insufficient
• For Example
• In liquid preparations containing indiffusible solids such as; chalk, aromatic chalk,
powder succinyl sulphathiazole and sulphadimidine (in mixture) and calamine
and Zinc oxide (in lotion), a thickening agent is necessary to obtain an elegant
product from which uniform dose can be removed
Physical Incompatibilities: Insolubility
• Insoluble powders e.g. sulphur, certain corticosteroids and antibiotics are difficult
to wet with water, wetting agent are used.
• Example:
• Saponins for sulphur continuing lotions.
• Polysorbates for parenteral suspensions of corticosteroids and antibiotics.
• The deflocculating action of excess surface active agent may be cause claying.
This may be controlled by reducing the surfactant concentration.
Physical Incompatibilities: Insolubility
• Potent insoluble drugs are converted into salt form.
• Example:
• An alkaloidal salt for an alkaloids
• Sodium salt of barbiturates for the corresponding free compound.
• Constituents of alcoholic vegetable extract may precipitate.
• When a resinous tincture is added to the water. The water-insoluble resin
agglomerates forming indiffusible clots.
Physical Incompatibilities: Liquefaction
• When low melting point solids are powdered together with high melting point
solids, a liquid or soft mass is produced due to lowering of melting point of the
mixture to below room temperature
Example:
• Among the medicaments exhibiting this behavior are any pair of the following;
• Camphor, menthol, phenol, thymol, and chloral hydrate.
• Sodium salicylate or aspirin with phenazone.
Physical Incompatibilities: Immiscibility
• Immiscibility occurs between two liquids ingredients
• Oil (fixed oil) in water emulsion (emulsification or solubilization)
• Concentrated hydrophilic solutions of volatile oils such as spirits and
concentrated water used as adjuncts. (For example flavoring agents) in aqueous
preparations, are either gradually diluted with the vehicle before admixture with
the remaining ingredients or poured slowly into vehicle with constant stirring.
• Addition of high concentration of electrolytes to mixtures in which vehicle is a
saturated aqueous solution of a volatile oil causes the oil to separate and collect
as an unsightly surface layer.
• Example: Potassium citrate mixture BPC, in which the large quantity of soluble
solid, salts out the lemon oil and to disperse this evenly quillaia tincture is added
as a suspending agent or emulsifying agents.
Chemical Incompatibilities
• Chemical incompatibilities occur as a result of chemical reaction;
• Effervescence
• Precipitation
• Color changes
• It can be immediate or it can be delayed.
Chemical Incompatibilities: Types
• Following are the types of reaction that occurs;
• Oxidation
• Hydrolysis
• Polymerization
• Combustion reactions
• Isomerization
• Decarboxylation
• Formation of insoluble complexes
Chemical Incompatibilities: Oxidation
• Oxidation refers to the addition of oxygen or removal of hydrogen.
• The factors which leads to oxidation are includes;
• Pressure of oxygen: Increased pressure of oxygen will lead to oxidation of the
ingredients
• Light: Presence of light may cause photochemical oxidation reactions
• Temperature: Elevated temperature leads to oxidation of ingredients
• pH: Every drug has its optimum pH for stability. Therefore, change in the pH may
affect the stability of the drug and may cause its oxidation.
• Pharmaceutical dosage form: Oxidation reactions occurs in solutions faster than
in solid dosage forms
Chemical Incompatibilities: Oxidation
• Presence of pre-oxidants: Presence of pre-oxidants leads to the oxidation of
ingredients
For example; metals, peroxides.
• Type of solvents/ vehicle used: Oxidation occurs faster in aqueous solvent /
vehicles than others.
• Presence of unsaturated bonds: Presence of unsaturation (double or triple bond)
leads to easier oxidation than saturated bonds.
Chemical Incompatibilities: Oxidation
• Preventive measures taken to prevent oxidation reactions includes
• Addition of antioxidants: To avoid oxidation antioxidants are used
For example; Vitamin E, Vitamin C and inorganic sulfur compounds e.g. polysulfide and
thiosulfate.
• Protection form pre-oxidants: Addition of chemicals which forms complexes with
metals
For example; EDTA, Benzalkonium chloride
• Protection from light: The drug ingredients must be protected from light by using
dark containers for packing, storage of formulation in dark places, or by packaging
with substances which absorbs light
For example; oxybenzene
Chemical Incompatibilities: Oxidation
• Choice dosage form: Suitable dosage form must be selected which reduces the
possibility of oxidation.
For example; solids dosage forms are better over solutions.
• Maintenance of pH: Buffers must be used to maintain the pH for the stability of
the drug ingredients.
• Choice of suitable solvent/ vehicle: Hydroalcoholic or alcoholic vehicles are used
instead of aqueous vehicle to overcome oxidation.
• Maintenance of temperature: Storage at low temperature prevent oxidation.
• Protection from air: Oxidation can be avoided by packing the formulation in well
closed container or by the replacement of oxygen by nitrogen inside the
container.
Chemical Incompatibilities: Oxidation
• Chemical groups that are susceptible to oxidation:
• Phenolic compounds – Phenylephrine
• Catechol derivatives – Adrenaline, Nor-adrenaline
• Antibiotics – Tetracycline
• Oils – Fixed oils and Volatile oils
• Vitamins – Lipid soluble vitamins and Water soluble vitamins
Chemical Incompatibilities: Hydrolysis
• Breakdown of chemical compound in presence of moisture/water is called
Hydrolysis
• Hydrolysis is of two types;
1. Ionic hydrolysis: The breakdown of ionic compound into its positive and
negative ions.
Example: codeine phosphate reversibly broken down to codeine and phosphate.
2. Molecular hydrolysis: It is defined as the breakdown of whole molecule into its
components.
Example: Acetyl salicylic acid irreversibly broken down into salicylic acid and acetic acid.
Chemical Incompatibilities: Hydrolysis
• The factors which leads to hydrolysis are mentioned below;
• Presence of water: Presence of water leads to hydrolysis of formulation
ingredients.
• Use of water for vehicle: Using of water as vehicle for formulation may cause
hydrolysis.
• pH: Every drug has its optimum pH for stability. Therefore, change in the pH may
affect the stability of the drug and may cause its hydrolysis.
• For example; optimum pH for Atropine is 3.1 – 4.5
• Temperature: High temperature during autoclaving may leads to hydrolysis of the
formulation.
Chemical Incompatibilities: Hydrolysis
• Preventive measures to prevent hydrolysis during compounding includes;
• Protection from moisture: it can be done by packing with such substances which
are impermeable to water.
• Addition of dehydration agents: hydrolysis can also be avoided by the addition of
substances that absorb water.
• For example; Silica gel, Calcium carbonate.
• Use of vehicle: Hydrolysis can be prevented by using vehicles other than water.
• For example; alcohol.
• Maintenance of pH: Buffers must be used to maintain the pH for the stability of
the drug ingredients.
• Using of surfactants: Surfactants must be used which cause miscall formation.
Chemical Incompatibilities: Hydrolysis
• Reducing the solubility: By reducing the solubility of substances drugs can be
protected against hydrolysis.
• For example; suspensions.
• Complex formation: Formation of complexes must be done which protect the
drug from effects of water.
• Chemical groups undergo hydrolysis:
• Esters – Benzocaine, Procaine
• Amides – Chloramphenicol, Sulphonamides, Procainamide
• Nitriles – drugs containing NO2, NO3, N2O
Chemical Incompatibilities: Polymerization
• Polymerization is a process in which small repeating units called monomers are
bonded to form a long chain polymer
• Formaldehyde convert into para formaldehyde which appears in the form of precipitate. So,
to avoid, formaldehyde must be stored at suitable temperature.
• Ampicillin at high temperature form polymers which causes allergy.
• The following factors induces polymerization;
• Light: light may cause polymerization in the formulation or individual ingredients.
• Solvent/ vehicle: certain solvents induce polymerization.
• pH: Every drug has its optimum pH for stability. Therefore, change in the pH may
affect the stability of the drug and may cause its polymerization of monomers.
• Temperature: High temperature causes polymerization of ingredients.
Chemical Incompatibilities: Polymerization
• Preventive measures to prevent Polymerization reactions during compounding;
• Protection from light: The drug ingredients must be protected from light by using
dark containers for packing, storage of ingredients in dark places, or by packaging
with substances which absorbs light.
• For example; oxybenzene.
• Use of vehicle: Polymerization can be prevented by using suitable vehicles.
• Maintenance of pH: Buffers must be used to maintain the pH for the stability of
the drug ingredients.
• Maintenance of temperature: Storage at suitable low temperature prevent
polymerization.
Chemical Incompatibilities: Combustion
Reaction
• Such reactions takes place when the pharmaceutical dosage form contain
substances with different charges.
• Example: Surfactant with +ve and –ve charges
Chemical Incompatibilities: Isomerization
• Conversion of drug to its isomer is called isomerization
• Isomers have same molecular formula and different structural formula
(arrangement of atoms).
• There are two types of isomerism;
1. Optical isomerism: these are expressed by dextro rotatory and levo rotatory.
• Example: L-adrenaline is converted into d-adrenaline by change in pH and temperature.
• D-tubocurarine is more active than its L form.
2. Geometrical isomerism: these are expressed by Cis and Trans. Most of the
times the Cis form is more active than trans form.
• Example: Cis form of Vitamin A is more active.
Chemical Incompatibilities: Isomerization
• The following factors induces isomerization;
• Solvent/ vehicle: certain solvents induce isomerization of ingredients.
• pH: Every drug has its optimum pH for stability. Therefore, change in the pH may
affect the stability of the drug and may cause its isomerization.
• Temperature: Variation in temperature causes isomerization of ingredients.
• Impurities: certain impurities leads to isomerization of ingredients.
Chemical Incompatibilities: Isomerization
• Preventive measures to prevent isomerization of ingredients during compounding
includes;
• Use of vehicle: isomerization can be prevented by using suitable vehicles.
• Maintenance of pH: Buffers must be used to maintain the pH for the stability of
the drug ingredients.
• Maintenance of temperature: Storage at suitable temperature prevent
isomerization of drug ingredients.
• Protection from Impurities: Drugs can be protected against impurities by filtering
them out.
Chemical Incompatibilities: Decarboxylation
Reaction
• In general it can be understand by; evolution of Carbon dioxide during the
formulation.
• Carbon dioxide is evolved if a carbonate or bicarbonate is dispensed in a liquid
medicine containing an acid of an acidic drug. To prevent leakage or explosion the
reaction must be completed before the preparation is bottled.
• In some instances the reaction is slow and should be hastened by using a hot
vehicle.
• All drugs containing bicarbonate are not sterilized at high temperature.
Chemical Incompatibilities: Decarboxylation
Reaction
• Preventive measures are taken to prevent isomerization of ingredients during
compounding;
• Use of vehicle: Decarboxylation can be prevented by using suitable non-acidic
vehicles.
• Maintenance of pH: Buffers must be used to maintain the pH for the stability of
the drug ingredients.
• Maintenance of temperature: Storage at suitable temperature prevent
decarbocylation of drug ingredients.
Chemical Incompatibilities: Formation of
Insoluble Complexes
• Complexes are formed either due to drug or due to adjuncts used in formulation.
• Drugs: tetracycline form complex with heavy metalsremoved with EDTA
molecules.
• Adjuncts: Many molecular adjuncts used which medicaments and preservations
are bound to the macromolecules or trapped within miscall. The behavior is most
common in non-ionic macromolecules.
• Therapeutic activity or adjunct efficacy may be seriously impaired by complex
formation particularly emulgents (macrobol esters and ethers) and solublizers
(polysorbates) exhibit this phenomenon

More Related Content

What's hot

Pharmaceutical Incompatibilities
Pharmaceutical IncompatibilitiesPharmaceutical Incompatibilities
Pharmaceutical IncompatibilitiesParag Jain
 
Pharmaceutical incompatibility
Pharmaceutical incompatibilityPharmaceutical incompatibility
Pharmaceutical incompatibilityrohit kamboj
 
Biphasic liquid an overview
Biphasic liquid an overviewBiphasic liquid an overview
Biphasic liquid an overviewSmit Bhadani
 
Pharmaceutical Incompatibility
Pharmaceutical IncompatibilityPharmaceutical Incompatibility
Pharmaceutical IncompatibilityRavikumar Patil
 
Incompatibilities in prescription
Incompatibilities in prescriptionIncompatibilities in prescription
Incompatibilities in prescriptionNisha Mhaske
 
Physical incompatibilities and chemical incompatibilities
Physical incompatibilities and chemical incompatibilitiesPhysical incompatibilities and chemical incompatibilities
Physical incompatibilities and chemical incompatibilitiesshital trivedi
 
Incompatibility in Prescription
Incompatibility in PrescriptionIncompatibility in Prescription
Incompatibility in Prescriptionbvocmithilesh
 
lab manual of Community Pharmacy and management.pdf
lab manual of Community Pharmacy and management.pdflab manual of Community Pharmacy and management.pdf
lab manual of Community Pharmacy and management.pdfSumit Tiwari
 
Liquid dosage forms
Liquid dosage formsLiquid dosage forms
Liquid dosage formsMj Aspa
 
Semisolid dosage forms (Ointments)
Semisolid dosage forms (Ointments)Semisolid dosage forms (Ointments)
Semisolid dosage forms (Ointments)Krutika Pardeshi
 
Incompatibilities in prescription
Incompatibilities in prescriptionIncompatibilities in prescription
Incompatibilities in prescriptionSantuMistree4
 
Introduction to Pharmaceutical Chemistry
 Introduction to Pharmaceutical Chemistry Introduction to Pharmaceutical Chemistry
Introduction to Pharmaceutical ChemistryPriti Kokate
 
Pharmaceutical incompatibilities by monia jannatul kubra
Pharmaceutical incompatibilities by monia jannatul kubraPharmaceutical incompatibilities by monia jannatul kubra
Pharmaceutical incompatibilities by monia jannatul kubraMoniaJanmatulKubra
 
Schedule M-Jurisprudence
Schedule M-JurisprudenceSchedule M-Jurisprudence
Schedule M-JurisprudenceSaiyam Agarwal
 

What's hot (20)

Pharmaceutical Incompatibilities
Pharmaceutical IncompatibilitiesPharmaceutical Incompatibilities
Pharmaceutical Incompatibilities
 
Pharmaceutical incompatibility
Pharmaceutical incompatibilityPharmaceutical incompatibility
Pharmaceutical incompatibility
 
Biphasic liquid an overview
Biphasic liquid an overviewBiphasic liquid an overview
Biphasic liquid an overview
 
Ointment ppt
Ointment pptOintment ppt
Ointment ppt
 
Pharmaceutical Incompatibility
Pharmaceutical IncompatibilityPharmaceutical Incompatibility
Pharmaceutical Incompatibility
 
Incompatibilities in prescription
Incompatibilities in prescriptionIncompatibilities in prescription
Incompatibilities in prescription
 
State pharmacy council and joint state pharmacy council
State pharmacy council and joint state pharmacy councilState pharmacy council and joint state pharmacy council
State pharmacy council and joint state pharmacy council
 
Physical incompatibilities and chemical incompatibilities
Physical incompatibilities and chemical incompatibilitiesPhysical incompatibilities and chemical incompatibilities
Physical incompatibilities and chemical incompatibilities
 
Elixirs
ElixirsElixirs
Elixirs
 
Incompatibility in Prescription
Incompatibility in PrescriptionIncompatibility in Prescription
Incompatibility in Prescription
 
Cathartics
CatharticsCathartics
Cathartics
 
lab manual of Community Pharmacy and management.pdf
lab manual of Community Pharmacy and management.pdflab manual of Community Pharmacy and management.pdf
lab manual of Community Pharmacy and management.pdf
 
Liquid dosage forms
Liquid dosage formsLiquid dosage forms
Liquid dosage forms
 
Semisolid dosage forms (Ointments)
Semisolid dosage forms (Ointments)Semisolid dosage forms (Ointments)
Semisolid dosage forms (Ointments)
 
Sterile Dosage Forms
Sterile Dosage FormsSterile Dosage Forms
Sterile Dosage Forms
 
Incompatibilities in prescription
Incompatibilities in prescriptionIncompatibilities in prescription
Incompatibilities in prescription
 
Introduction to Pharmaceutical Chemistry
 Introduction to Pharmaceutical Chemistry Introduction to Pharmaceutical Chemistry
Introduction to Pharmaceutical Chemistry
 
Incompatibility
IncompatibilityIncompatibility
Incompatibility
 
Pharmaceutical incompatibilities by monia jannatul kubra
Pharmaceutical incompatibilities by monia jannatul kubraPharmaceutical incompatibilities by monia jannatul kubra
Pharmaceutical incompatibilities by monia jannatul kubra
 
Schedule M-Jurisprudence
Schedule M-JurisprudenceSchedule M-Jurisprudence
Schedule M-Jurisprudence
 

Similar to Pharmaceutical incompatibilities

Pharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptx
Pharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptxPharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptx
Pharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptxSudipta Roy
 
Incompatibilities of drug admixtures
Incompatibilities of drug admixtures Incompatibilities of drug admixtures
Incompatibilities of drug admixtures Ali Al Samawy
 
Factors affecting drug degradation
Factors affecting drug degradationFactors affecting drug degradation
Factors affecting drug degradationSnehal Patel
 
Accelerated Stability Testing.
Accelerated Stability Testing. Accelerated Stability Testing.
Accelerated Stability Testing. Maha Alkhalifah
 
Incompatibilities in Prescription.pptx
Incompatibilities in Prescription.pptxIncompatibilities in Prescription.pptx
Incompatibilities in Prescription.pptxAditya Sharma
 
Routes of drug degredation
Routes of drug degredationRoutes of drug degredation
Routes of drug degredationSourav Shipu
 
prodrug-.pptx Medicinal chemistry 7 SEMESTER
prodrug-.pptx  Medicinal chemistry 7 SEMESTERprodrug-.pptx  Medicinal chemistry 7 SEMESTER
prodrug-.pptx Medicinal chemistry 7 SEMESTERdipika51
 
Drug excipient interaction
Drug excipient interactionDrug excipient interaction
Drug excipient interactionNeeraj Ojha
 
UNIT II - LIQUIDS.pptx
UNIT II -  LIQUIDS.pptxUNIT II -  LIQUIDS.pptx
UNIT II - LIQUIDS.pptxUmarFarook93
 
Pharmaceutical Incompatibility : Mr. P. B. Jadhav
Pharmaceutical Incompatibility : Mr. P. B. JadhavPharmaceutical Incompatibility : Mr. P. B. Jadhav
Pharmaceutical Incompatibility : Mr. P. B. JadhavPRASHANT JADHAV
 
Product Stability Studies & Stability Testing
Product Stability Studies & Stability Testing Product Stability Studies & Stability Testing
Product Stability Studies & Stability Testing Amit Attri
 
Drug physicochemics.pptx
Drug physicochemics.pptxDrug physicochemics.pptx
Drug physicochemics.pptxbreenaawan
 
Pharmaceutical incompatibility and classification
Pharmaceutical incompatibility and classificationPharmaceutical incompatibility and classification
Pharmaceutical incompatibility and classificationsy6000217
 
PHYSICOCHEMICAL PROPERTIES OF DRUG MOLECU;E.pptx
PHYSICOCHEMICAL PROPERTIES OF DRUG MOLECU;E.pptxPHYSICOCHEMICAL PROPERTIES OF DRUG MOLECU;E.pptx
PHYSICOCHEMICAL PROPERTIES OF DRUG MOLECU;E.pptxbreenaawan
 

Similar to Pharmaceutical incompatibilities (20)

Pharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptx
Pharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptxPharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptx
Pharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptx
 
Incompatibilities of drug admixtures
Incompatibilities of drug admixtures Incompatibilities of drug admixtures
Incompatibilities of drug admixtures
 
Factors affecting drug degradation
Factors affecting drug degradationFactors affecting drug degradation
Factors affecting drug degradation
 
Accelerated Stability Testing.
Accelerated Stability Testing. Accelerated Stability Testing.
Accelerated Stability Testing.
 
Incompatibilities in Prescription.pptx
Incompatibilities in Prescription.pptxIncompatibilities in Prescription.pptx
Incompatibilities in Prescription.pptx
 
DRUG INTERACTION.ppt
DRUG INTERACTION.pptDRUG INTERACTION.ppt
DRUG INTERACTION.ppt
 
Module 1a.pptx
Module 1a.pptxModule 1a.pptx
Module 1a.pptx
 
Routes of drug degredation
Routes of drug degredationRoutes of drug degredation
Routes of drug degredation
 
Samani
SamaniSamani
Samani
 
prodrug-.pptx Medicinal chemistry 7 SEMESTER
prodrug-.pptx  Medicinal chemistry 7 SEMESTERprodrug-.pptx  Medicinal chemistry 7 SEMESTER
prodrug-.pptx Medicinal chemistry 7 SEMESTER
 
Drug interactions
Drug interactionsDrug interactions
Drug interactions
 
Drug excipient interaction
Drug excipient interactionDrug excipient interaction
Drug excipient interaction
 
UNIT II - LIQUIDS.pptx
UNIT II -  LIQUIDS.pptxUNIT II -  LIQUIDS.pptx
UNIT II - LIQUIDS.pptx
 
12 incompatability
12 incompatability12 incompatability
12 incompatability
 
Pharmaceutical Incompatibility : Mr. P. B. Jadhav
Pharmaceutical Incompatibility : Mr. P. B. JadhavPharmaceutical Incompatibility : Mr. P. B. Jadhav
Pharmaceutical Incompatibility : Mr. P. B. Jadhav
 
Product Stability Studies & Stability Testing
Product Stability Studies & Stability Testing Product Stability Studies & Stability Testing
Product Stability Studies & Stability Testing
 
Drug physicochemics.pptx
Drug physicochemics.pptxDrug physicochemics.pptx
Drug physicochemics.pptx
 
Pharmaceutical incompatibility and classification
Pharmaceutical incompatibility and classificationPharmaceutical incompatibility and classification
Pharmaceutical incompatibility and classification
 
Bioavailability
BioavailabilityBioavailability
Bioavailability
 
PHYSICOCHEMICAL PROPERTIES OF DRUG MOLECU;E.pptx
PHYSICOCHEMICAL PROPERTIES OF DRUG MOLECU;E.pptxPHYSICOCHEMICAL PROPERTIES OF DRUG MOLECU;E.pptx
PHYSICOCHEMICAL PROPERTIES OF DRUG MOLECU;E.pptx
 

More from Zainab&Sons

Proteins lecture 3
Proteins lecture 3Proteins lecture 3
Proteins lecture 3Zainab&Sons
 
Strutural organisation of proteins
Strutural organisation of proteinsStrutural organisation of proteins
Strutural organisation of proteinsZainab&Sons
 
Chemistry of lipids
Chemistry of lipidsChemistry of lipids
Chemistry of lipidsZainab&Sons
 
Lipids digestion
Lipids digestionLipids digestion
Lipids digestionZainab&Sons
 
Chemistry of lipids ii
Chemistry of lipids iiChemistry of lipids ii
Chemistry of lipids iiZainab&Sons
 
Lipid catabolism (fatty acid oxidation)
Lipid catabolism (fatty acid oxidation)Lipid catabolism (fatty acid oxidation)
Lipid catabolism (fatty acid oxidation)Zainab&Sons
 
Glycogen metabolism
Glycogen metabolismGlycogen metabolism
Glycogen metabolismZainab&Sons
 
Citric acid cycle (2)
Citric acid cycle (2)Citric acid cycle (2)
Citric acid cycle (2)Zainab&Sons
 
Cholesterol biosynthesis
Cholesterol biosynthesisCholesterol biosynthesis
Cholesterol biosynthesisZainab&Sons
 
Carb lec 2 & 3 slides
Carb lec 2 & 3 slidesCarb lec 2 & 3 slides
Carb lec 2 & 3 slidesZainab&Sons
 
Transcription translation
Transcription translationTranscription translation
Transcription translationZainab&Sons
 

More from Zainab&Sons (20)

Proteins lecture 3
Proteins lecture 3Proteins lecture 3
Proteins lecture 3
 
Strutural organisation of proteins
Strutural organisation of proteinsStrutural organisation of proteins
Strutural organisation of proteins
 
Lipoproteins
LipoproteinsLipoproteins
Lipoproteins
 
Lipids
LipidsLipids
Lipids
 
Chemistry of lipids
Chemistry of lipidsChemistry of lipids
Chemistry of lipids
 
Lipids digestion
Lipids digestionLipids digestion
Lipids digestion
 
Chemistry of lipids ii
Chemistry of lipids iiChemistry of lipids ii
Chemistry of lipids ii
 
Hormones
HormonesHormones
Hormones
 
Enzymes
EnzymesEnzymes
Enzymes
 
Urea cycle
Urea cycleUrea cycle
Urea cycle
 
Lipid catabolism (fatty acid oxidation)
Lipid catabolism (fatty acid oxidation)Lipid catabolism (fatty acid oxidation)
Lipid catabolism (fatty acid oxidation)
 
Glycogenolysis
GlycogenolysisGlycogenolysis
Glycogenolysis
 
Glycogen metabolism
Glycogen metabolismGlycogen metabolism
Glycogen metabolism
 
Gluconeogenesis
GluconeogenesisGluconeogenesis
Gluconeogenesis
 
Citric acid cycle (2)
Citric acid cycle (2)Citric acid cycle (2)
Citric acid cycle (2)
 
Cholesterol biosynthesis
Cholesterol biosynthesisCholesterol biosynthesis
Cholesterol biosynthesis
 
Carbohydrate
CarbohydrateCarbohydrate
Carbohydrate
 
Carb lec 2 & 3 slides
Carb lec 2 & 3 slidesCarb lec 2 & 3 slides
Carb lec 2 & 3 slides
 
Transcription translation
Transcription translationTranscription translation
Transcription translation
 
Nucleic acids
Nucleic acidsNucleic acids
Nucleic acids
 

Recently uploaded

ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfSpandanaRallapalli
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxDr.Ibrahim Hassaan
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 

Recently uploaded (20)

ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdf
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 

Pharmaceutical incompatibilities

  • 2. Pharmaceutical Incompatibilities • A problem arises during the pharmaceutical compounding of two or more substances because of their therapeutic, physical or chemical properties the substances are said to be incompatible • Incompatibility is the result of mixing two or more antagonistic substances and is detected by changes in physical and chemical or therapeutic qualities • It may affect the safety efficacy and appearance of a medicine • A prescription is considered to possess an incompatibility when the combination of its ingredients adversely effects the appearance, elegance, safety or therapeutic efficacy
  • 3. Classification • In general we can say there are two types of incompatibilities; • Minor incompatibilities (which do not harm or which can be easily avoided) • Major incompatibilities (which should not be dispensed) • Incompatibilities can be classified into three classes; • Physical incompatibilities • Chemical incompatibilities • Therapeutic incompatibilities
  • 4. Therapeutic Incompatibilities • Undesirable pharmacological interactions between two or more ingredients that leads to • Potentiation of each other’s therapeutic effect • Destruction of effectiveness of any ingredient • Occurrence of toxic manifestations within the patient • Therapeutic incompatibility arises when a drug error, dosage error or a dosage form error is made either by the physician in prescribing or by pharmacist in counselling, prescription handling or compounding.
  • 5. Therapeutic Incompatibilities: Drug Error • Drug error can be made either by the physician or by the pharmacist. It can be due to; • Writing or speaking error by the physician in the verbal or non-verbal prescription • Reading or hearing error by the pharmacist in prescription handling • Example: • Such problems tends to arise with, incorrect drug due to trademark or nomenclature error. • Alphaden – Mineral supplement • Alphalin – Vitamin A product • Alphyllin – A diuretic
  • 6. Therapeutic Incompatibilities: Contraindicated Drugs • Pharmacist should take history before dispensing the drug to the patient. So that; • He must be aware of any sort of drug interaction • He avoid dispensing a drug which undergo renal clearance, to a patient with renal insufficiency • He avoid dispensing a drug which mainly undergo hepatic metabolism, to a patient with liver dysfunctioning • He avoid dispensing morphine to an asthmatic patient • He avoid dispensing vasoconstrictor to a hypersensitive patient
  • 7. Therapeutic Incompatibilities: Dosage Form Error • These are the errors which occurs due to • If the physician has asked to compound topical product and pharmacist compounded an oral product • If topical products is swallowed by the patient • If skin dosages are instilled into eyes, nose or ears • If auxiliary label is not mentioned on the final compounded product
  • 8. Therapeutic Incompatibilities: Dosage Error • If there is an error in dosage requirement, i.e. how to take? When to take? How much to take? How long to take? • Over dosage; Excessive single dosage because of decimal errors. It occurs if the doctor wrote it wrong or pharmacist read it in a wrong way. • Excessive daily dose; suppose doctor has to write ‘after every 4 hours’ but mistakenly he wrote ‘after every 1 hour’ then by this error the patient will receive over dosage of the medicament. • Addictive or synergistic combination; Two drugs may have such relation that when they are administered together, leads to more intense effect. • Example: Morphine with Barbiturates produce intense CNS depressant action.
  • 9. Therapeutic Incompatibilities: Dosage Error • Antagonistic combination; Two drugs may have such relation leads to under dosage to the patients. • Example: The reduction of the anticoagulant effect of warfarin when an agent that accelerates its hepatic metabolism, such as phenobarbital. • In case of emulsion or suspension if patient forget to shaken the preparation before usage, leads to unequal dosage to user.
  • 10. Physical Incompatibilities • Physical incompatibilities are those incompatibilities in which the physical properties of ingredients produce a mixture unacceptable in appearance or results in inaccuracy of dosage. • Physical incompatibilities can arise due to following reasons • Insolubility • Liquefaction • Immiscibility
  • 11. Physical Incompatibilities: Insolubility • In complete solution • Addition of wrong solvents e.g. gum-alcohol, silicon-water • Amount of solvent is insufficient • For Example • In liquid preparations containing indiffusible solids such as; chalk, aromatic chalk, powder succinyl sulphathiazole and sulphadimidine (in mixture) and calamine and Zinc oxide (in lotion), a thickening agent is necessary to obtain an elegant product from which uniform dose can be removed
  • 12. Physical Incompatibilities: Insolubility • Insoluble powders e.g. sulphur, certain corticosteroids and antibiotics are difficult to wet with water, wetting agent are used. • Example: • Saponins for sulphur continuing lotions. • Polysorbates for parenteral suspensions of corticosteroids and antibiotics. • The deflocculating action of excess surface active agent may be cause claying. This may be controlled by reducing the surfactant concentration.
  • 13. Physical Incompatibilities: Insolubility • Potent insoluble drugs are converted into salt form. • Example: • An alkaloidal salt for an alkaloids • Sodium salt of barbiturates for the corresponding free compound. • Constituents of alcoholic vegetable extract may precipitate. • When a resinous tincture is added to the water. The water-insoluble resin agglomerates forming indiffusible clots.
  • 14. Physical Incompatibilities: Liquefaction • When low melting point solids are powdered together with high melting point solids, a liquid or soft mass is produced due to lowering of melting point of the mixture to below room temperature Example: • Among the medicaments exhibiting this behavior are any pair of the following; • Camphor, menthol, phenol, thymol, and chloral hydrate. • Sodium salicylate or aspirin with phenazone.
  • 15. Physical Incompatibilities: Immiscibility • Immiscibility occurs between two liquids ingredients • Oil (fixed oil) in water emulsion (emulsification or solubilization) • Concentrated hydrophilic solutions of volatile oils such as spirits and concentrated water used as adjuncts. (For example flavoring agents) in aqueous preparations, are either gradually diluted with the vehicle before admixture with the remaining ingredients or poured slowly into vehicle with constant stirring. • Addition of high concentration of electrolytes to mixtures in which vehicle is a saturated aqueous solution of a volatile oil causes the oil to separate and collect as an unsightly surface layer. • Example: Potassium citrate mixture BPC, in which the large quantity of soluble solid, salts out the lemon oil and to disperse this evenly quillaia tincture is added as a suspending agent or emulsifying agents.
  • 16. Chemical Incompatibilities • Chemical incompatibilities occur as a result of chemical reaction; • Effervescence • Precipitation • Color changes • It can be immediate or it can be delayed.
  • 17. Chemical Incompatibilities: Types • Following are the types of reaction that occurs; • Oxidation • Hydrolysis • Polymerization • Combustion reactions • Isomerization • Decarboxylation • Formation of insoluble complexes
  • 18. Chemical Incompatibilities: Oxidation • Oxidation refers to the addition of oxygen or removal of hydrogen. • The factors which leads to oxidation are includes; • Pressure of oxygen: Increased pressure of oxygen will lead to oxidation of the ingredients • Light: Presence of light may cause photochemical oxidation reactions • Temperature: Elevated temperature leads to oxidation of ingredients • pH: Every drug has its optimum pH for stability. Therefore, change in the pH may affect the stability of the drug and may cause its oxidation. • Pharmaceutical dosage form: Oxidation reactions occurs in solutions faster than in solid dosage forms
  • 19. Chemical Incompatibilities: Oxidation • Presence of pre-oxidants: Presence of pre-oxidants leads to the oxidation of ingredients For example; metals, peroxides. • Type of solvents/ vehicle used: Oxidation occurs faster in aqueous solvent / vehicles than others. • Presence of unsaturated bonds: Presence of unsaturation (double or triple bond) leads to easier oxidation than saturated bonds.
  • 20. Chemical Incompatibilities: Oxidation • Preventive measures taken to prevent oxidation reactions includes • Addition of antioxidants: To avoid oxidation antioxidants are used For example; Vitamin E, Vitamin C and inorganic sulfur compounds e.g. polysulfide and thiosulfate. • Protection form pre-oxidants: Addition of chemicals which forms complexes with metals For example; EDTA, Benzalkonium chloride • Protection from light: The drug ingredients must be protected from light by using dark containers for packing, storage of formulation in dark places, or by packaging with substances which absorbs light For example; oxybenzene
  • 21. Chemical Incompatibilities: Oxidation • Choice dosage form: Suitable dosage form must be selected which reduces the possibility of oxidation. For example; solids dosage forms are better over solutions. • Maintenance of pH: Buffers must be used to maintain the pH for the stability of the drug ingredients. • Choice of suitable solvent/ vehicle: Hydroalcoholic or alcoholic vehicles are used instead of aqueous vehicle to overcome oxidation. • Maintenance of temperature: Storage at low temperature prevent oxidation. • Protection from air: Oxidation can be avoided by packing the formulation in well closed container or by the replacement of oxygen by nitrogen inside the container.
  • 22. Chemical Incompatibilities: Oxidation • Chemical groups that are susceptible to oxidation: • Phenolic compounds – Phenylephrine • Catechol derivatives – Adrenaline, Nor-adrenaline • Antibiotics – Tetracycline • Oils – Fixed oils and Volatile oils • Vitamins – Lipid soluble vitamins and Water soluble vitamins
  • 23. Chemical Incompatibilities: Hydrolysis • Breakdown of chemical compound in presence of moisture/water is called Hydrolysis • Hydrolysis is of two types; 1. Ionic hydrolysis: The breakdown of ionic compound into its positive and negative ions. Example: codeine phosphate reversibly broken down to codeine and phosphate. 2. Molecular hydrolysis: It is defined as the breakdown of whole molecule into its components. Example: Acetyl salicylic acid irreversibly broken down into salicylic acid and acetic acid.
  • 24. Chemical Incompatibilities: Hydrolysis • The factors which leads to hydrolysis are mentioned below; • Presence of water: Presence of water leads to hydrolysis of formulation ingredients. • Use of water for vehicle: Using of water as vehicle for formulation may cause hydrolysis. • pH: Every drug has its optimum pH for stability. Therefore, change in the pH may affect the stability of the drug and may cause its hydrolysis. • For example; optimum pH for Atropine is 3.1 – 4.5 • Temperature: High temperature during autoclaving may leads to hydrolysis of the formulation.
  • 25. Chemical Incompatibilities: Hydrolysis • Preventive measures to prevent hydrolysis during compounding includes; • Protection from moisture: it can be done by packing with such substances which are impermeable to water. • Addition of dehydration agents: hydrolysis can also be avoided by the addition of substances that absorb water. • For example; Silica gel, Calcium carbonate. • Use of vehicle: Hydrolysis can be prevented by using vehicles other than water. • For example; alcohol. • Maintenance of pH: Buffers must be used to maintain the pH for the stability of the drug ingredients. • Using of surfactants: Surfactants must be used which cause miscall formation.
  • 26. Chemical Incompatibilities: Hydrolysis • Reducing the solubility: By reducing the solubility of substances drugs can be protected against hydrolysis. • For example; suspensions. • Complex formation: Formation of complexes must be done which protect the drug from effects of water. • Chemical groups undergo hydrolysis: • Esters – Benzocaine, Procaine • Amides – Chloramphenicol, Sulphonamides, Procainamide • Nitriles – drugs containing NO2, NO3, N2O
  • 27. Chemical Incompatibilities: Polymerization • Polymerization is a process in which small repeating units called monomers are bonded to form a long chain polymer • Formaldehyde convert into para formaldehyde which appears in the form of precipitate. So, to avoid, formaldehyde must be stored at suitable temperature. • Ampicillin at high temperature form polymers which causes allergy. • The following factors induces polymerization; • Light: light may cause polymerization in the formulation or individual ingredients. • Solvent/ vehicle: certain solvents induce polymerization. • pH: Every drug has its optimum pH for stability. Therefore, change in the pH may affect the stability of the drug and may cause its polymerization of monomers. • Temperature: High temperature causes polymerization of ingredients.
  • 28. Chemical Incompatibilities: Polymerization • Preventive measures to prevent Polymerization reactions during compounding; • Protection from light: The drug ingredients must be protected from light by using dark containers for packing, storage of ingredients in dark places, or by packaging with substances which absorbs light. • For example; oxybenzene. • Use of vehicle: Polymerization can be prevented by using suitable vehicles. • Maintenance of pH: Buffers must be used to maintain the pH for the stability of the drug ingredients. • Maintenance of temperature: Storage at suitable low temperature prevent polymerization.
  • 29. Chemical Incompatibilities: Combustion Reaction • Such reactions takes place when the pharmaceutical dosage form contain substances with different charges. • Example: Surfactant with +ve and –ve charges
  • 30. Chemical Incompatibilities: Isomerization • Conversion of drug to its isomer is called isomerization • Isomers have same molecular formula and different structural formula (arrangement of atoms). • There are two types of isomerism; 1. Optical isomerism: these are expressed by dextro rotatory and levo rotatory. • Example: L-adrenaline is converted into d-adrenaline by change in pH and temperature. • D-tubocurarine is more active than its L form. 2. Geometrical isomerism: these are expressed by Cis and Trans. Most of the times the Cis form is more active than trans form. • Example: Cis form of Vitamin A is more active.
  • 31. Chemical Incompatibilities: Isomerization • The following factors induces isomerization; • Solvent/ vehicle: certain solvents induce isomerization of ingredients. • pH: Every drug has its optimum pH for stability. Therefore, change in the pH may affect the stability of the drug and may cause its isomerization. • Temperature: Variation in temperature causes isomerization of ingredients. • Impurities: certain impurities leads to isomerization of ingredients.
  • 32. Chemical Incompatibilities: Isomerization • Preventive measures to prevent isomerization of ingredients during compounding includes; • Use of vehicle: isomerization can be prevented by using suitable vehicles. • Maintenance of pH: Buffers must be used to maintain the pH for the stability of the drug ingredients. • Maintenance of temperature: Storage at suitable temperature prevent isomerization of drug ingredients. • Protection from Impurities: Drugs can be protected against impurities by filtering them out.
  • 33. Chemical Incompatibilities: Decarboxylation Reaction • In general it can be understand by; evolution of Carbon dioxide during the formulation. • Carbon dioxide is evolved if a carbonate or bicarbonate is dispensed in a liquid medicine containing an acid of an acidic drug. To prevent leakage or explosion the reaction must be completed before the preparation is bottled. • In some instances the reaction is slow and should be hastened by using a hot vehicle. • All drugs containing bicarbonate are not sterilized at high temperature.
  • 34. Chemical Incompatibilities: Decarboxylation Reaction • Preventive measures are taken to prevent isomerization of ingredients during compounding; • Use of vehicle: Decarboxylation can be prevented by using suitable non-acidic vehicles. • Maintenance of pH: Buffers must be used to maintain the pH for the stability of the drug ingredients. • Maintenance of temperature: Storage at suitable temperature prevent decarbocylation of drug ingredients.
  • 35. Chemical Incompatibilities: Formation of Insoluble Complexes • Complexes are formed either due to drug or due to adjuncts used in formulation. • Drugs: tetracycline form complex with heavy metalsremoved with EDTA molecules. • Adjuncts: Many molecular adjuncts used which medicaments and preservations are bound to the macromolecules or trapped within miscall. The behavior is most common in non-ionic macromolecules. • Therapeutic activity or adjunct efficacy may be seriously impaired by complex formation particularly emulgents (macrobol esters and ethers) and solublizers (polysorbates) exhibit this phenomenon